- China
- /
- Aerospace & Defense
- /
- SHSE:688510
Wuxi Hyatech Co.,Ltd.'s (SHSE:688510) Shares Climb 25% But Its Business Is Yet to Catch Up
Wuxi Hyatech Co.,Ltd. (SHSE:688510) shareholders are no doubt pleased to see that the share price has bounced 25% in the last month, although it is still struggling to make up recently lost ground. But the gains over the last month weren't enough to make shareholders whole, as the share price is still down 3.3% in the last twelve months.
Since its price has surged higher, given close to half the companies in China have price-to-earnings ratios (or "P/E's") below 31x, you may consider Wuxi HyatechLtd as a stock to avoid entirely with its 48.3x P/E ratio. Nonetheless, we'd need to dig a little deeper to determine if there is a rational basis for the highly elevated P/E.
With earnings growth that's superior to most other companies of late, Wuxi HyatechLtd has been doing relatively well. The P/E is probably high because investors think this strong earnings performance will continue. If not, then existing shareholders might be a little nervous about the viability of the share price.
See our latest analysis for Wuxi HyatechLtd
Want the full picture on analyst estimates for the company? Then our free report on Wuxi HyatechLtd will help you uncover what's on the horizon.How Is Wuxi HyatechLtd's Growth Trending?
There's an inherent assumption that a company should far outperform the market for P/E ratios like Wuxi HyatechLtd's to be considered reasonable.
If we review the last year of earnings growth, the company posted a terrific increase of 338%. The latest three year period has also seen a 13% overall rise in EPS, aided extensively by its short-term performance. So we can start by confirming that the company has actually done a good job of growing earnings over that time.
Turning to the outlook, the next year should generate growth of 31% as estimated by the three analysts watching the company. With the market predicted to deliver 40% growth , the company is positioned for a weaker earnings result.
With this information, we find it concerning that Wuxi HyatechLtd is trading at a P/E higher than the market. Apparently many investors in the company are way more bullish than analysts indicate and aren't willing to let go of their stock at any price. Only the boldest would assume these prices are sustainable as this level of earnings growth is likely to weigh heavily on the share price eventually.
The Bottom Line On Wuxi HyatechLtd's P/E
Wuxi HyatechLtd's P/E is flying high just like its stock has during the last month. It's argued the price-to-earnings ratio is an inferior measure of value within certain industries, but it can be a powerful business sentiment indicator.
We've established that Wuxi HyatechLtd currently trades on a much higher than expected P/E since its forecast growth is lower than the wider market. When we see a weak earnings outlook with slower than market growth, we suspect the share price is at risk of declining, sending the high P/E lower. Unless these conditions improve markedly, it's very challenging to accept these prices as being reasonable.
A lot of potential risks can sit within a company's balance sheet. Our free balance sheet analysis for Wuxi HyatechLtd with six simple checks will allow you to discover any risks that could be an issue.
If P/E ratios interest you, you may wish to see this free collection of other companies with strong earnings growth and low P/E ratios.
Valuation is complex, but we're here to simplify it.
Discover if Wuxi HyatechLtd might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SHSE:688510
Wuxi HyatechLtd
Research, develops, manufactures, and sells aero-engine parts and forged medical orthopedic implants in China and internationally.
High growth potential with excellent balance sheet.